Загрузка...

Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study

BACKGROUND: Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear. METHODS: This was a population-based cohort study in 2005–2015. Associations between metformin use and gastric non-cardia and cardia adenocarcinomas were examined within two cohorts; a diabetes c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Cancer
Главные авторы: Zheng, Jiaojiao, Xie, Shao-Hua, Santoni, Giola, Lagergren, Jesper
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889304/
https://ncbi.nlm.nih.gov/pubmed/31591459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0598-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!